Why Ultra-High-Yield UPS Is Investing $48 Million to Control the Temperature

UPS is investing $48 million in 27 temperature-controlled facilities to serve the healthcare sector, particularly for GLP-1 weight-loss drugs and temperature-sensitive medications. This strategic shift is part of the company's broader turnaround effort to move away from low-margin customers toward high-margin healthcare customers. Management expects the second half of 2026 to be an inflection point, with revenue per package rising despite lower overall revenue.